Trade Show News

Advances of Qilu Pharmaceutical’s QL1706 in Clinical Research Presented at ASCO Annual Meeting

by

JINAN, China, May 31, 2023 /PRNewswire/ — The American Society of Clinical Oncology (ASCO) recently announced the selected abstracts for the prestigious ASCO 2023 Annual Meeting. Four clinical research abstracts on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, were accepted in the Poster Session. Two of the posters focus on the latest clinical research progress of Qilu … Read more

Blue Lake Biotechnology to Be Featured at the Biotechnology Innovation Organization (BIO) International Convention

by

ATHENS, Ga. and LOS GATOS, Calif., May 31, 2023 /PRNewswire/ — Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company harnessing the full breadth of the immune system to protect against serious infectious diseases, announced today that company CEO Biao He, Ph.D., will present and host one-on-one partnering meetings at the 2023 Biotechnology Innovation Organization International … Read more

SuperOps.ai Launches Mental Wellness Initiative at Channel Partners Conference & Expo to Support MSPs

by

Small business owners, including owners of MSPs, are disproportionately affected when it comes to mental health issues, but few seek help. 65% of entrepreneurs have dealt with anxiety. 4 out of 5 small business owners are experiencing poor mental health. The SuperOps.ai #TogetherWeCan initiative sets out to support MSPs, let them know they are not … Read more

Collaborators at the Keio and Osaka Universities Present Key Non-Clinical Data with Stable/Functional-Induced Regulatory T Cells (S/F-iTregs) in Autoimmune Disease Models

by

OSAKA, Japan, May 29, 2023 /PRNewswire/ — RegCell collaborators from Keio University and Osaka University presented key data at ISID 2023 Tokyo Satellite Meeting. Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and other autoimmune markers related to Pemphigus. Collaborators also reported that S/F-iTregs generated … Read more

Menarini Group compartilha nova análise do estudo clínico EMERALD do ORSERDU® (Elacestrant) em câncer de mama metastático na ASCO 2023

by

ORSERDU (elacestrant) foi aprovado em janeiro de 2023 pelo FDA para câncer de mama avançado ou metastático positivo para receptor de estrogênio (ER), receptor 2 do fator de crescimento epidérmico humano (HER2) negativo com mutações ESR1 (ESR1-mut), que são encontradas em até 40% dos tumores  Em pacientes cujos tumores abrigam ESR1-mut, uma análise post-hoc anterior … Read more

Ascentage Pharma Presents Updated Results from Multiple Clinical Studies at American Society of Clinical Oncology Annual Conference

by

SUZHOU, China, and ROCKVILLE, Md., May 25, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that 4 of its abstracts were selected for presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. These studies … Read more

Jazz Pharmaceuticals to Host Zanidatamab KOL Investor Webcast on June 2, 2023

by

Zanidatamab data to be featured in oral presentation at ASCO 2023 Webcast to follow on June 2, 2023 at 6:45 p.m. CT DUBLIN, May 25, 2023 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host a webcast to review the zanidatamab biliary tract cancers (BTC) data being featured in an oral presentation at the 2023 American … Read more

Government of Japan Expresses its Pledge of US$200 Million to GHIT Fund/UNDP Replenishment

by

“GHIT 3.0,” its third five-year plan announced. TOKYO, May 25, 2023 /PRNewswire/ — At the G7 Hiroshima Summit 2023, Prime Minister Fumio Kishida announced the Government of Japan’s pledge to contribute US$200 million to the Global Health Innovative Technology Fund (GHIT Fund)/United Nations Development Programme (UNDP). This pledge supports the GHIT Fund’s third phase of operations, … Read more

Biopharma-Führungskräfte treffen sich auf dem F&E- und Qualitätsgipfel von Veeva, um Innovationen für die Branche und die Patienten voranzutreiben

by

Bayer, Boehringer Ingelheim, GSK, LEO Pharma, Recordati, Syneos Health und weitere Unternehmen  teilen ihre Erkenntnisse zur Steigerung der Effizienz im gesamten Produktentwicklungszyklus BARCELONA, Spanien, 24. Mai 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Führungskräfte von Bayer, Boehringer Ingelheim, GSK, LEO Pharma, Recordati und Syneos Health zu den Rednern des Veeva R&D and Quality … Read more

Nuvalent to Participate in the TD Cowen 4th Annual Oncology Innovation Summit

by

CAMBRIDGE, Mass., May 24, 2023 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the TD Cowen 4th Annual Oncology Innovation … Read more